All Industries

Primer Selected for the 2024 GSV Cup 50

Spark Metro PR

Primer has been named to the 2024 GSV Cup 50 out of 1,000 nominations of pre-seed and seed-stage companies. The GSV Cup, presented by Google Cloud and GSV Ventures, and supported by HolonIQ, recognizes the world's most innovative digital learning and workforce skills startups. The GSV Cup 50 will be featured at the 15th Annual ASU+GSV Summit, the preeminent global gathering for “Pre-K to Gray” education leaders, in San Diego, CA. The GSV Cup 50 highlights the most promising startups that support learners across the Pre-K to Gray spectrum, distributed across early childhood education, K-12, higher education, workforce learning, and adult consumer learning. All nominees were evaluated against GSV’s “Five P’s” framework: People, Product, Potential, Predictability, and Purpose. "Being chosen for the GSV Cup 50 is a great honor, highlighting our alignment with GSV's values and our commitment to innovation in digital learning,” said Mark Naufel, Founder of Primer. “Being part of this elite group starts a new chapter for Primer, as we continue to revolutionize the idea of a lifelong adaptive learning experience powered by an AI personal companion." “This year’s GSV Cup was both incredibly competitive and incredibly inspiring,” said Deborah Quazzo, Managing Partner of GSV Ventures and Co-founder of the ASU+GSV Summit. “The GSV Cup 50 are undoubtedly the stars of tomorrow. With almost 80% of the companies focused on leveraging AI, they’ve got both eyes on the future of education – not just what we can see now, but what we can build beyond view. We’re so excited to see the transformative effects of these companies over the next five, ten, even fifteen years.” The 2024 GSV Cup 50 companies are poised to make a global impact, with 34% headquartered outside of the United States and representation from 15 unique countries. This year’s GSV Cup 50 also represent a variety of diverse perspectives and experiences, with 66% of the companies led by female or BIPOC founder(s). The GSV Cup 50 join a prestigious group of past Cup startups, including Ello, Ethena, LingoAce, Prenda, Stride, TransfrVR, and TeachFX. See Primer and all of the companies selected to the GSV Cup 50 at https://www.asugsvsummit.com/gsv-cup. About Primer Primer is an AI personal companion poised to revolutionize the digital learning landscape, with the market expected to reach heights of $370 billion by 2026. Leveraging a patent-pending, generative AI system, Primer offers tailored, engaging experiences that enhance both learning and daily life. Beyond traditional education, Primer learns and grows with each user, continuously evolving to meet their personal needs. It’s this seamless ability to customize learning for everyone, from inquisitive schoolchildren to professionals advancing their careers, that underscores Primer’s dedication to ensuring no one navigates through life without a worldclass advocate. About ASU+GSV Summit Now celebrating its 15th year, the ASU+GSV Summit has become the world's most important and impactful gathering of leaders across "Pre-K to Gray" education and workforce learning. Hosted in San Diego, the annual event attracts over 7,000 in-person and 10,000 virtual registrants. Past GSV keynote speakers and honorees have included Presidents George Bush, Barack Obama and Vicente Fox Quesada, Former Secretaries of Education Arne Duncan and John King, Surgeon General Vivek Murthy, Gina Raimondo, Reed Hastings, John Legend, Condoleezza Rice, Justice Sandra Day O'Connor, Priscilla Chan, Laurene Powell Jobs, and more. ### For Media Relations contact: Mark Naufel,, info@primer.net Contact Details Primer Mark Naufel +1 302-597-6768 info@primer.net Company Website https://primer.net/

February 07, 2024 12:10 AM Eastern Standard Time

Image

Copper Property CTL Pass Through Trust Issues Monthly Reporting Package for January 2024

Copper Property CTL Pass Through Trust

Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 8-K containing its monthly report for the period ended January 31, 2024. An aggregate total distribution of $6.34 million or $0.084562 per trust certificate will be paid on February 12, 2024, to certificateholders of record as of February 9, 2024. This distribution is lower than the Trust’s typical monthly distribution primarily due to annual expenses paid in January, particularly insurance and Trustee fees. In addition, the Trust obtained its required semi-annual BOV’s in January. Additional information, including the Trust’s Monthly and Quarterly Reports, as well as other filings with the Securities and Exchange Commission (“SEC”) can be accessed via the Trust’s website at www.ctltrust.net. About Copper Property CTL Pass Through Trust Copper Property CTL Pass Through Trust (the “Trust”) was established to acquire 160 retail properties and 6 warehouse distribution centers (the “Properties”) from J.C. Penney as part of its Chapter 11 plan of reorganization. The Trust’s operations consist solely of owning, leasing and selling the Properties. The Trust’s objective is to sell the Properties to third-party purchasers as promptly as practicable. The Trustee of the trust is GLAS Trust Company LLC. The Trust is externally managed by an affiliate of Hilco Real Estate LLC. The Trust is intended to be treated, for tax purposes, as a liquidating trust within the meaning of United States Treasury Regulation Section 301.7701-4(d). For more information, please visit https://www.ctltrust.net/. Forward Looking Statement This news release contains certain “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “our vision,” “plan,” “potential,” “preliminary,” “predict,” “should,” “will,” or “would” or the negative thereof or other variations thereof or comparable terminology and include, but are not limited to, the Trust’s expectations or beliefs concerning future events and stock price performance. The Trust has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Trust believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond its control. These factors, including those discussed in the Trust’s Registration Statement on Form 10 filed with the Securities and Exchange Commission (the “SEC”), may cause its actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. For a further list and description of such risks and uncertainties, please refer to the Trust’s filings with the SEC that are available at www.sec.gov. The Trust cautions you that the list of important factors included in the Trust’s SEC filings may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this news release may not in fact occur. The Trust undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. Contact Details Jessica Cummins - Investor Relations +1 847-313-4755 jcummins@hilcoglobal.com Company Website https://ctltrust.net/about/default.aspx

February 06, 2024 04:15 PM Eastern Standard Time

Eat To Think: The Power of Nutrient-Dense Foods for Enhanced Cognitive Function!

YourUpdateTV

No one wants to slip into their later years with a failing memory or inability to think clearly and make decisions. Recently Peter Castleman, Author of “Eat to Think: Big Pharma Wants You to Take Pills Forever. We Don't.”, conducted a satellite media tour to share tips and advice on how to use nutritious food to help support your brain health and cognitive function. A video accompanying this announcement is available at: https://youtu.be/-jYERLSPs80 If you’re over 50, you’re most likely a part of the growing number of people who fear a gradual loss of brain function, otherwise known as cognitive decline or dementia. It’s normal to worry. But there is good news. Cognitive decline is mostly the result of lifestyle choices, not genetics. It is simply a story of “too little/too much “- too little of the nutrients your brain needs daily to maintain health and too much of the foods, drugs, and poor lifestyle choices that damage the brain. Nutrient Survival, the pioneering force in Special Ops Grade nutritional innovation, announces the launch of the book “ Eat to Think,” co-authored by Peter M. Castleman and B. Eric Christianson and available now on Amazon. The book explores the beauty of the brain and how it is designed to regenerate forever while empowering readers with Six Pillars of Brilliance to strengthen brain health and longevity. Both Christianson, CEO of Nutrient Survival, and Castleman, Chairman of Nutrient Institute, a non-profit dedicated to improving human nutrition, were spurred to write “Eat to Think” after researching the damage to human health created by common nutritional habits and an over dependence on “Big Pharma” to address health symptoms versus root issues. “In today’s society we have come to accept the inevitable degeneration of our brains and mental function, which does not need to be our fate,” insists Castleman. “Declining mental faculties with age is typically a product of ‘neuroinflammation,’ a process that gradually damages brain cells but can be reversed with proper nutrition. We have the power to regenerate our brain cells within literal reach of our pantries and refrigerators.” Much of the nutritional science and functional ingredients discussed in “Eat to Think'' are incorporated into Nutrient Survival’s newest BrainCare® product launch, the Brain Omega 3 Bar®. An all-natural solution to support brain performance, each Brain Omega 3 Bar® features a patent-pending combination of 1,948mg of Omega 3s, 40 essential nutrients including 27 vitamins and minerals, naturally occurring flavonoids and 8g of protein, all offering better bioavailability of ingredients to nourish both your brain and body. Brain Omega 3 Bar - Fig & Dark Chocolate contains sweet ripe figs, rich dark chocolate, and tart cranberry pieces. Brain Omega 3 Bar - Fig & Roasted Peanut offers ground peanut with sweet ripe figs, semi-sweet chocolate, and creamy peanut morsels. Both flavors are blended with rolled oats, organic rice crisps, milled flax and hemp seeds and feature the following: ● 1,948 mg of Omega 3 (EPA 430 mg + DHA 323 mg + ALA 1,160mg + SDA 35mg) ● 40 essential nutrients ● 27 vitamins and minerals ● 8g of protein including 1.5g of collagen ● Natural flavonoids from semi-sweet chocolate, figs and peanuts ● No artificial colors, flavors or preservatives ● Gluten free The Brain Omega 3 Bar® is available for $2.75 a bar in bags of 15 at nutrientsurvival.com. For more info on the book visit eattothink.com - About Nutrient Survival Nutrient Survival LLC is an end-to-end food technology company offering nutrient dense survival food for emergencies and every day. Nutrient Survival has experienced explosive growth since its introduction in 2020, behind its patented nutrient dense products and compelling brand proposition. Designed to the same nutritional requirements of the US military for its elite Special Ops units, the brand delivers six times more nutrition than any other survival food brand. Nutrient Survival meals designed using the nutritional standards specified in Department of Defense pubs AR 40-25/OPNAVINST 10110.1/MCO 10110.49/AFI 44–141 for Restricted Rations, those rations intended for use on special operations missions. Meals meet or exceed standards for 23 nutrients on a per calorie basis. Neither the US Armed Forces nor the US Federal Government has approved, endorsed or authorized this product. The opinions expressed are solely those of the individual's. About the Authors Peter M. Castleman. Chairman of Nutrient Survival; Chairman of WISEcode; Chairman of Nutrient Institute. A lifetime entrepreneur who for the past decade has been dedicated to improving human nutrition and information about what is in our foods. Castleman graduated from Duke University at the top of his class in Economics, became a Professor at Harvard, then worked on Wall Street. Castleman bought North Face outerwear company when it was going bankrupt and turned it into a 3 billion per year company and then sold it. He did the same with Igloo, Herbalife, and many others. Castleman aims to empower consumers to manage wellness, instead of being controlled by Big Food, Big Ag, and Big Pharma. With good information, Castleman believes humans can make informed decisions with their lifestyle choices. B. Eric Christianson. CEO of Nutrient Survival; Army Veteran; Airborne Ranger qualified; West Point Distinguished Cadet graduate. After a career of leading iconic food brands at Fortune 100 companies, Christianson found his lifelong calling when he was asked by Castleman to build a company called Nutrient Survival. Born at the start of the pandemic, Nutrient Survival is a disruptive end-to-end food company based in Reno-Tahoe, Nevada, that redefines survival food – and all food for that matter – with performance nutrition. With its patented products, Nutrient Survival brings top shelf, delicious, Special Ops grade nutrition. Designed to the same elite nutritional standards of the military for its Special Operations Forces but intended for people like us. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

February 06, 2024 03:31 PM Eastern Standard Time

Video

MultiversX Blockchain Data Now Embedded in Global Internet Data Streams via Google BigQuery

STORM Partners

Sibiu, Romania, February 06, 2023 - MultiversX, the leader in sharding technology across public distributed networks, has now become available on Google BigQuery. This marks a significant milestone, and opens access to blockchain data in an easy manner, with Google embedding data streams from the MultiversX blockchain into the internet and making it readily available. Google BigQuery is an enterprise-grade, petabyte-scale cloud data warehouse, with a cost-effective pay-as-you-go pricing model. Anyone with a Google Account can now get insights about the MultiversX network, such as the top 100 block producers, without running specialized software and waiting to sync the ledger. Other quick-to-use sample queries available directly on the MultiversX dataset page are: details about the latest blocks, daily transaction count, largest EGLD transfers in a specific timeframe or top used smart contracts. MultiversX network on-chain data on BigQuery: https://console.cloud.google.com/marketplace/product/bigquery-public-data/blockchain-analytics-multiversx-mainnet-eu Developers and projects using MultiversX for conducting and recording actions on-chain are now granted access to an important new instrument for their toolkit. With the help of Google BigQuery, they can perform in-depth product analysis to understand their users’ behavior, and evaluate what their product development priorities are. “ Analyzing and interpreting data to reveal useful insights and information about product usage is a science barely explored compared to its potential utility for the web3 space. Having Google resolve a big part of the hassle for MultiversX projects is an important step towards making dApps better, more useful, and more appealing to the masses. “ said Lucian Mincu, MultiversX Foundation CIO. The service is provided through the MultiversX ETL, a tool developed by the core team of the Layer 1 smart contract platform, which extracts, transforms and feeds Google BigQuery with blockchain data at hourly intervals. Google Cloud involvement in the MultiversX ecosystem extends beyond this important integration. The two leading technology companies are co-working on multiple initiatives to accelerate Web3, including a startup accelerator program, hackathons and developer initiatives, and joint business developments, such as the presence of MultiversX as partner in the Google Cloud booth at GITEX Global, Dubai 2023. About MultiversX MultiversX is a highly scalable public blockchain via sharding, decentralized through 3200 validator nodes, built to solve the three fundamental problems critical for widespread, global adoption: transition from dial-up to broadband, significant UX paradigm shift, and simplicity of self-custody. About Google BigQuery Google BigQuery is a Google Cloud Platform service that serves as a cloud-based and scalable enterprise data warehouse for rapid SQL queries and interactive analysis of massive datasets. The solution is known for its quick processing time and large data capabilities. Distributed by STORM Partners. Contact Adrian Bono for interviews and quotes - adrian.bono@storm.partners or telegram @STORMPartners Contact Details MultiversX Media Contact Dan Voicu, Head of Communications dan.voicu@multiversx.com

February 06, 2024 12:02 PM Eastern Standard Time

Image

Atlantic Lithium sees potential for big resource expansion at Ewoyaa after extension drilling

Atlantic Lithium Limited

Atlantic Lithium Ltd Chief Geologist and Head of Business Development Len Kolff joined Proactive's Stephen Gunnion with details of more high-grade intersections that were revealed during extension drilling outside of the confirmed resource area at its Ewoyaa project in Ghana. Speaking from Cape Town during the Mining Indaba, Kolff said there is potential to significantly expand the lithium resource beyond the current 35.3 million tonne estimate. These results include the longest intercept from the 2023 drilling program, featuring an 83-metre section with 1% lithium oxide, located outside the previously confirmed resource area. Kolff expressed optimism about updating the resource estimate by the second or third quarter of this year, pending further assay results from the 2023 drilling program and completion of planned drilling activities. For 2024, the priority remains on enlarging the resource base to support the development of the Ewoyaa project while assisting the mine build team with necessary sterilisation drilling around proposed plant sites. Contact Details Editorial +44 20 7989 0813 uk@proactiveinvestors.com Company Website https://www.proactiveinvestors.co.uk

February 06, 2024 11:38 AM Eastern Standard Time

Video

BP rallies on share buyback plan; focus turns to volatility around Uber and PayPal - OptionsDesk

Options Desk

OptionsDesk's Sebastian Blanco joined Proactive's Stephen Gunnion with a preview of quarterly earnings on Wednesday from Uber and PayPal. Following a strong rise in Uber's share price last year, Blanco said meeting expectations won't be enough for Uber; unless it beats expectations its shares could come under pressure. PayPal's shares are down over the past year as it faces increasing competition in the payments space and investors will watch its results keenly to see how it is addressing this. Blanco also commented in a surge in BP's share price after it released better-than-expected profits and details of a significant share buyback program. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 06, 2024 10:29 AM Eastern Standard Time

Video

Salus GRC Hires Alan Knepfer as Chief Revenue Officer

Salus GRC

Salus GRC recently welcomed Alan Knepfer as Chief Revenue Officer. Reporting to Chief Executive Officer William Mulligan, Mr. Knepfer is responsible for leading Salus GRC’s global revenue operations, with a focus on driving sales and marketing excellence and identifying strategic growth initiatives. He joins Salus GRC during an impressive period of growth. Amassing clients with over $200B in AUM over the past two quarters alone, Salus GRC has also created a collective of talented, deeply experienced, and highly respected resources in the field, with the singular mission of providing unparalleled service. Salus GRC provides a full suite of tech-enabled Governance, Risk and Compliance (“GRC”) support to private fund managers and other financial services firms, with offerings that include regulatory registration and filing services, compliance program development and ongoing support, regulatory exam assistance, compliance training and education, regulatory due diligence, and cybersecurity. Salus GRC aspires to be the employer of choice in the GRC space, attracting experienced professionals who bring a singular focus on providing the highest level of client service. Over time, Salus GRC expects to expand its service offering to include ESG, regulatory technology (RegTech), and GRC support for other industry verticals. Mr. Knepfer brings over 25 years of experience leading, building, and reinventing scalable revenue organizations. Most recently he was the Chief Revenue Officer at RadarFirst, a Privacy Incident Management software provider. In addition, he has held numerous senior management positions including President and Chief Revenue Officer of Comodo Cybersecurity and Global Head of Sales and Customer Success at NASDAQ. “I am thrilled to welcome Alan as our Chief Revenue Officer and member of the Executive Management Team,” said Mr. Mulligan. “With a proven track record of achieving exceptional results and building sustainable, profitable businesses, Alan is the right visionary leader to join our great team in helping drive our next phase of strategic growth at Salus GRC. His passion for Customer Success and Marketing will be invaluable as we continue to help clients maximize our tech-enabled solutions.” “Salus GRC is uniquely positioned to capitalize on a fragmented market in search of a leader,” said Mr. Knepfer. “I’m thrilled to join this experienced team of industry superstars – who have each built an incredible following in this space – and to combine our efforts towards building the leading tech platform for GRC services. Our people and our collective focus are a powerful combination, positioning us well for years of growth, at an accelerated rate rarely seen in any business.” About Salus GRC: Launched in the Spring of 2023, in partnership with financial sponsor Charlesbank Capital Partners, Salus GRC provides GRC services to private fund managers, registered investment advisers, CFTC-registered managers, and broker-dealers. Offerings include regulatory registration and filing services, compliance program development and ongoing support, regulatory exam assistance, compliance training and education, and regulatory due diligence. About Charlesbank Capital Partners: Based in Boston and New York, Charlesbank Capital Partners is a middle-market private investment firm with more than $17 billion of capital raised since inception. Charlesbank focuses on management-led buyouts and growth capital financings, and engages in opportunistic credit and technology investments. The firm seeks to build companies with sustainable competitive advantage and excellent prospects for growth. For more information, please visit www.charlesbank.com. Contact Details Salus GRC Monique Stehle mstehle@salusgrc.com Charlesbank Ryan FitzGibbon / Dan Ivers / Peter Gavaris pro-charlesbank@prosek.com Company Website https://www.salusgrc.com/

February 06, 2024 10:15 AM Eastern Standard Time

Image

Prodigy Biotech Enters into a Partnership Agreement with Leading Cancer Center to Advance Products to Improve Outcomes in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Prodigy Biotech

Prodigy is the first company to join the MSK Therapeutic Accelerator. The accelerator program launch was announced at the MSK Life Sciences Innovation Summit in New York City on January 26, 2024. Prodigy and Memorial Sloan Kettering Cancer Center (MSK) will co-develop a product targeting Enterococcus sp. to treat microbial dysbiosis in patients undergoing allogenic hematopoietic stem cell transplantation. The product will be built on Prodigy’s polyclonal Immunoglobulin Y (IgY) technology that has shown promising preclinical data in models of alcoholic liver disease. Prodigy and MSK have entered into a sponsored research agreement through the MSK Therapeutics Accelerator program to evaluate Prodigy’s product candidate for the improvement of outcomes in patients undergoing allogenic hematopoietic stem cell transplantation (allo-HCT). The MSK Therapeutic Accelerator project will be led by Jonathan Peled, MD, PhD, Assistant Attending Physician, MSK. Through his pioneering research, Dr. Peled and his team at MSK have significantly advanced the role of the microbiome in impacting outcomes in patients undergoing allo-HCT. Dr. Peled’s work revealed that patients undergoing allo-HCT have enterococcal domination events and these domination events lead to worse overall survival and higher graft vs. host disease (GvHD)-related mortality. Dr. Peled has previously demonstrated in preclinical models that resetting the gut microbiome has profound outcomes in mitigating disease severity. In this collaboration, Prodigy’s Enterococcus sp. neutralizing antibodies will be evaluated in preclinical models of GvHD and product candidates will be developed to move into clinical development. Furthermore, Prodigy is pleased to have Dr. Peled join and help build its allo-HCT Scientific Advisory Board (SAB). In addition to the sponsored research, MSK will provide expertise and institutional resources through the MSK Therapeutics Accelerator to aid in the development of a drug candidate for patients undergoing allogenic hematopoietic stem cell transplantation. MSK’s Therapeutic Accelerator Program is a partnership program between MSK and technology and pharmaceutical companies to advance novel therapeutics through all stages of drug development. The program brings together innovative healthcare companies with MSK’s community of clinical and scientific experts to establish groundbreaking collaborations that can have a tangible impact on treatment or management of cancer. Satish Chandran, CEO of Prodigy said, “ We are delighted to collaborate and partner with MSK’s Therapeutic Accelerator Program and Dr. Peled to develop product(s) for patients undergoing allo-HCT. Given the significant morbidity and mortality associated with the disease, it is incumbent upon all of us to find solutions that have the potential to save lives and restore normalcy to these patients. We have been very pleased with the robust preclinical proof-of-concept data of our product PROD-AH-001, (Hepatology, 2023) for alcoholic hepatitis which is currently being readied for an IND submission with the FDA.” Dr. Jonathan Peled of MSK said, "Patients who are treated with allo-HCT experience the most extreme microbiome injuries observed in any clinical setting. There is an urgent need to develop approaches that can mitigate this and prevent the expansion of potentially pathogenic bacteria. We hypothesize that attenuating the expansion of Enterococcus within the gastrointestinal tract will prevent bloodstream infections with this bacterium and potentially also ameliorate GVHD.” Dr. Chandran presented information about this important new collaboration at the MSK Life Sciences Innovation Summit in New York City on January 26, 2024. About Allogenic Hematopoietic Stem Cell Transplantation Allo-HCTs have a chance to cure malignancies but are associated with high rate of complications and mortality. Allo-HCT can lead to various complications, affecting different organs due to the intense conditioning regimen and introduction of foreign immune cells. A significant concern after allo-HCT is graft-versus-host disease (GvHD), where the donor's immune cells mount an attack against the recipient and is a major cause of morbidity and non-relapse mortality in this patient population. There is a clear need of therapies that are able to improve outcomes in patients undergoing allogenic hematopoietic stem cell transplantation. About Prodigy Biotech, Inc. Prodigy Biotech is a privately held biopharmaceutical company focused on developing products using its polyclonal Immunoglobulin Y technology to selectively edit the microbiome while avoiding deleterious effects to the commensal microflora. The versatility of avian antibodies, IgY, allows for pathogen- specific neutralization capabilities not only to bacteria but also viruses, fungi, endotoxins, and even human secreted proteins such as cytokines and chemokines. A target agnostic approach and strategic collaborations with leading researchers in the microbiome field has allowed Prodigy to build a diverse pipeline ranging from modulating the gut microbiome in alcoholic liver disease (ALD) to modulating the lung microbiome in chronic obstructive pulmonary disease (COPD). Cautionary Note on Forward-Looking Statements: This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from our current expectations. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events or otherwise, after the date of this press release. Contact Details Prodigy Biotech, Inc. Satish Chandran satish.chandran@prodigybiotech.com Company Website https://www.prodigybiotech.com/

February 06, 2024 10:00 AM Eastern Standard Time

GoGlobal Announces International Business Expansion Expert Sissi Zhao as New Partner

GoGlobal

GoGlobal, a leading firm specializing in international business expansion services, recently announced the appointment of Sissi Zhao as a Partner, effective February 1st, 2024. This strategic move comes as part of the company’s ongoing efforts to enhance its leadership team and expand its global footprint, particularly in the fast-growth Asia Pacific (APAC) region. Sissi Zhao, a seasoned professional with an illustrious career in international business expansion, law, private equity and mergers & acquisitions, brings a wealth of knowledge and diversified insight to GoGlobal. Since joining GoGlobal, Sissi has played a pivotal role in the expansion of the company’s business operations in Asia. Her adept management of both inbound and outbound expansion opportunities has significantly contributed to the firm’s thriving success across the APAC region. Sissi's strategic foresight and deep understanding of the business landscapes in both Europe and APAC, bolstered by 12 years of living in Europe facilitating cross-border transactions and her six years’ onsite working experiences in Asia, equip her with an unparalleled ability to guide clients eyeing the dynamic Europe-Asia corridor for business expansion. "I am thrilled to step into this role and am committed to further propelling GoGlobal's growth. Our focus remains on closely collaborating with visionary companies eager to tap into the vast opportunities across the world. I am excited to leverage my expertise and facilitate our clients' expansion endeavors in today's dynamic and ever-evolving global economy,” says Sissi. "We congratulate Sissi on her well-deserved appointment and look forward to her contributions in shaping the future of GoGlobal," says Margaret Yip, Partner at GoGlobal. "Her exceptional skills and dedication are invaluable to our mission of facilitating seamless global expansion for our clients." About GoGlobal GoGlobal is a people-first international HR and Employer of Record (EOR) service provider, with a globally distributed, naturally diverse remote workforce. GoGlobal's technology enabled EOR solution allows companies of all sizes to hire people anywhere in the world without the need to set up a local entity, opening new doors to rapid expansion and growth. With a presence in over 137 countries on six continents and growing, GoGlobal helps clients recruit, hire, manage and pay exceptional talent – quickly, cost effectively and compliantly. Contact Details GoGlobal Bonnie Elgie +1 403-630-6164 bonnie.elgie@goglobalgeo.com

February 06, 2024 09:51 AM Eastern Standard Time

1 ... 440 441 442 443 444 ... 3763

Back